Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Revenue (2021 - 2025)

Historic Revenue for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to $3.4 million.

  • ProQR Therapeutics' Revenue fell 2016.94% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year decrease of 1203.49%. This contributed to the annual value of $20.5 million for FY2024, which is 19038.76% up from last year.
  • According to the latest figures from Q3 2025, ProQR Therapeutics' Revenue is $3.4 million, which was down 2016.94% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics' Revenue registered a high of $6.8 million during Q2 2024, and its lowest value of $170079.3 during Q1 2021.
  • Moreover, its 5-year median value for Revenue was $1.3 million (2023), whereas its average is $2.4 million.
  • Per our database at Business Quant, ProQR Therapeutics' Revenue soared by 64567.67% in 2022 and then tumbled by 4456.59% in 2023.
  • ProQR Therapeutics' Revenue (Quarter) stood at $273409.1 in 2021, then skyrocketed by 168.67% to $734578.1 in 2022, then surged by 381.01% to $3.5 million in 2023, then skyrocketed by 30.26% to $4.6 million in 2024, then fell by 26.79% to $3.4 million in 2025.
  • Its Revenue was $3.4 million in Q3 2025, compared to $4.3 million in Q2 2025 and $4.8 million in Q1 2025.